What are the priority nursing diagnoses for a patient with pneumonia?

The priority NANDA-I diagnoses for pneumonia typically include Ineffective Airway Clearance (00031) related to excessive secretions and inflammation, Impaired Gas Exchange (00030) related to alveolar-capillary membrane changes and ventilation-perfusion mismatch, and Hyperthermia (00007) related to the infectious process. Additional diagnoses may include Acute Pain (00132) related to pleuritic chest pain, Activity Intolerance (00092), and Risk for Deficient Fluid Volume (00028) from insensible losses.

How is oxygen therapy managed in a pneumonia nursing care plan?

Oxygen therapy for pneumonia is titrated to maintain SpO2 above 94% in most adults, or 88-92% in patients with chronic COPD who may rely on hypoxic drive. Delivery devices progress from nasal cannula (1-6 L/min) to simple mask (6-10 L/min) to non-rebreather mask (10-15 L/min) based on patient response. The nurse monitors SpO2 continuously or at minimum every 4 hours, assesses respiratory effort and work of breathing, and documents the FiO2 or flow rate with corresponding SpO2 and respiratory assessment findings.

What are the key nursing assessments for monitoring pneumonia progression?

Key assessments include respiratory rate, depth, and pattern every 2-4 hours; lung auscultation for adventitious sounds (crackles, rhonchi, diminished breath sounds); continuous pulse oximetry; sputum characteristics (color, consistency, amount, odor); temperature trending; level of consciousness and mental status changes (early sign of hypoxemia, especially in elderly); cough effectiveness; and monitoring WBC counts, procalcitonin, and chest X-ray findings for treatment response.

Pneumonia Nursing Care Plan Example

Pneumonia remains one of the leading causes of hospitalization and mortality worldwide, particularly among older adults and immunocompromised patients. Effective nursing care focuses on airway management, oxygenation, infection control, and early mobilization. This example demonstrates a comprehensive nursing care plan for community-acquired pneumonia using NANDA-I diagnoses, NIC interventions, and NOC outcomes.

Condition Overview

Pneumonia is an inflammatory condition of the lung parenchyma, primarily affecting the alveoli. It is most commonly caused by bacterial infection (Streptococcus pneumoniae is the most frequent bacterial pathogen in community-acquired pneumonia), though viral, fungal, and aspiration etiologies are also significant. The infection triggers an inflammatory response that fills alveoli with fluid, pus, and cellular debris, impairing gas exchange and producing the characteristic findings of consolidation on chest X-ray.

Community-acquired pneumonia (CAP) is classified by severity using tools such as the CURB-65 score (Confusion, Urea, Respiratory rate, Blood pressure, age 65+) or the Pneumonia Severity Index (PSI). These scores guide disposition decisions (outpatient treatment versus hospital admission versus ICU). Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) involve different pathogen profiles and require broader-spectrum antimicrobial coverage. Nursing care is essential in all forms, with airway clearance, oxygenation management, and early detection of deterioration as core responsibilities.

Typical Patient Presentation

Patients with pneumonia typically present with productive cough (producing purulent, rust-colored, or green sputum), fever and chills, pleuritic chest pain (sharp pain worsened by deep breathing or coughing), dyspnea, tachypnea, and fatigue. Elderly patients may present atypically with confusion, falls, or functional decline without prominent respiratory symptoms or fever, making clinical suspicion critical.

Physical examination reveals tachycardia, tachypnea (respiratory rate above 20), decreased SpO2, and focal lung findings including crackles (rales), bronchial breath sounds over the affected area, dullness to percussion, increased tactile fremitus, and egophony. Laboratory findings include leukocytosis with left shift, elevated CRP and procalcitonin, and possible lactate elevation in severe sepsis. Chest X-ray demonstrates lobar consolidation, patchy infiltrates, or bilateral diffuse opacities depending on the pathogen and severity.

Sample Assessment Scenario

Patient: Robert K., 71-year-old male, admitted from the emergency department with community-acquired pneumonia (right lower lobe consolidation on CXR). CURB-65 score: 3 (confused, RR 28, age 71). PMH: COPD (moderate), hypertension, former smoker (40 pack-year history, quit 5 years ago). Presenting with productive cough for 4 days producing thick, rust-colored sputum, fever to 102.8°F, rigors, right-sided pleuritic chest pain (6/10), and progressive dyspnea. Vital signs on admission: BP 98/62, HR 112, RR 28, SpO2 88% on room air, T 102.4°F. Assessment: Oriented to person only, using accessory muscles, diminished breath sounds right lower lobe with crackles and bronchial breath sounds, dullness to percussion RLL. Labs: WBC 18,200 with 14% bands, procalcitonin 4.2 ng/mL, lactate 2.8 mmol/L, BUN 28 mg/dL. Blood cultures drawn x2. Sputum culture obtained. Started on ceftriaxone 1g IV plus azithromycin 500 mg IV per CAP protocol.

NANDA-I Nursing Diagnoses

1. Impaired Gas Exchange (00030)

Definition: Excess or deficit in oxygenation and/or carbon dioxide elimination at the alveolar-capillary membrane.

Related factors: Alveolar-capillary membrane changes secondary to pneumonic consolidation, ventilation-perfusion mismatch.

Evidence: SpO2 88% on room air, tachypnea (RR 28), use of accessory muscles, confusion (altered mental status may indicate hypoxemia), tachycardia (HR 112), right lower lobe consolidation with diminished breath sounds.

2. Ineffective Airway Clearance (00031)

Definition: Inability to clear secretions or obstructions from the respiratory tract to maintain a clear airway.

Related factors: Excessive mucus production, retained secretions, infection, inflammation, pain limiting effective cough, fatigue, COPD history with impaired mucociliary clearance.

Evidence: Productive cough with thick, rust-colored sputum, crackles on auscultation, diminished breath sounds RLL, dyspnea, pleuritic pain limiting deep breathing and coughing.

3. Hyperthermia (00007)

Definition: Core body temperature above the normal diurnal range due to failure of thermoregulation.

Related factors: Infectious process (bacterial pneumonia).

Evidence: Temperature 102.4°F, rigors, tachycardia (partially fever-related), WBC 18,200 with 14% bands, procalcitonin 4.2 ng/mL.

4. Acute Pain (00132)

Definition: An unpleasant sensory and emotional experience associated with actual or potential tissue damage.

Related factors: Pleural inflammation secondary to pneumonia.

Evidence: Reports right-sided chest pain rated 6/10, pain worsened by deep breathing and coughing, splinting behavior limiting respiratory effort.

NIC Interventions

For Impaired Gas Exchange

Oxygen Therapy (3320):Initiate supplemental oxygen via nasal cannula at 2-4 L/min (note: COPD history — target SpO2 88-92% to avoid suppressing hypoxic drive). Titrate to maintain SpO2 within target range. Monitor continuous pulse oximetry. If SpO2 cannot be maintained, escalate to Venturi mask for precise FiO2 delivery. Assess for signs of CO2 retention (somnolence, headache, asterixis). Position in high Fowler's to maximize lung expansion. Monitor ABG results as ordered.
Respiratory Monitoring (3350): Assess respiratory rate, depth, pattern, and work of breathing every 2 hours. Auscultate lung sounds every 4 hours and document changes. Monitor mental status as a proxy for oxygenation (confusion may indicate worsening hypoxemia). Prepare for possible escalation to BiPAP or intubation if clinical trajectory worsens. Monitor serial chest X-rays for progression or resolution.

For Ineffective Airway Clearance

Airway Management (3140): Encourage deep breathing and coughing every 2 hours while awake. Teach splinting technique: have patient hold a pillow against the right chest wall during coughing to reduce pleuritic pain. Administer prescribed bronchodilators (especially given COPD history). Suction PRN if patient cannot expectorate effectively. Ensure adequate humidification of supplemental oxygen.
Chest Physiotherapy (3230): Position with affected (right) lung up to promote drainage via gravity. Implement incentive spirometry every 1-2 hours while awake (10 repetitions). Encourage early mobilization — dangle at bedside by day 1, ambulate by day 2 if hemodynamically stable. Promote adequate hydration (unless fluid-restricted) to thin secretions.

For Hyperthermia

Fever Treatment (3740): Monitor temperature every 4 hours. Administer antipyretics as ordered (acetaminophen 650 mg PO/PR q6h PRN for temp above 101°F). Encourage fluid intake to compensate for insensible losses (fever increases fluid requirements by approximately 500 mL per degree Celsius above normal). Provide lightweight clothing and bedding. Apply cool compresses if temperature exceeds 103°F. Monitor for sepsis criteria (qSOFA: altered mental status, RR 22+, SBP below 100).
Infection Control (6540): Administer antibiotics on schedule (time-critical medications). Obtain repeat blood cultures if fever persists after 48-72 hours of appropriate therapy. Monitor WBC and procalcitonin trends. Implement droplet precautions per facility protocol. Practice strict hand hygiene.

For Acute Pain

Pain Management (1400): Assess pain using a standardized scale every 4 hours and PRN. Administer analgesics as ordered — typically scheduled acetaminophen for dual antipyretic/analgesic effect, with low-dose opioids PRN for severe pleuritic pain (monitor respiratory depression). Teach non-pharmacological strategies: positioning, splinting, guided imagery. Time pain medication 30 minutes before incentive spirometry and mobility to support respiratory effort. Evaluate effectiveness 30-60 minutes post-intervention.

NOC Outcomes

Respiratory Status: Gas Exchange (0402)

Target: SpO2 maintained at 88-92% (COPD) on supplemental oxygen within 4 hours
Indicator: Mental status returns to baseline (oriented x3) within 24 hours
Indicator: ABG shows PaO2 above 60 mmHg on current oxygen therapy
Long-term: SpO2 above 92% on room air by discharge

Respiratory Status: Airway Patency (0410)

Target: Patient demonstrates effective cough with expectoration by day 2
Indicator: Sputum becomes thinner and lighter in color within 48-72 hours
Indicator: Lung sounds improving — diminished crackles, increased air entry RLL

Thermoregulation (0800)

Target: Temperature below 100.4°F within 48 hours of antibiotic initiation
Indicator: Absence of rigors by 24 hours
Indicator: WBC trending downward by 48-72 hours

Pain Level (2102)

Target: Pain reduced to 3/10 or less within 24 hours with intervention
Indicator: Patient able to perform deep breathing and coughing without guarding
Indicator: Pain does not limit incentive spirometry participation

Discharge Planning Considerations

Discharge readiness for pneumonia patients includes temperature below 100°F for 24 hours, adequate oral intake, stable or improving oxygenation on room air (or with home oxygen if prescribed), effective oral antibiotic transition, and functional capacity to manage ADLs. Ensure follow-up chest X-ray is ordered for 6-8 weeks post-discharge to confirm resolution (particularly important in patients over 50 to rule out underlying malignancy). Recommend pneumococcal and influenza vaccination if not up to date. Provide smoking cessation resources if applicable. Educate on completing the full antibiotic course and signs of relapse requiring return to care.

Building Your Own Pneumonia Care Plan

Pneumonia care plans must account for the specific pathogen (if identified), patient comorbidities (COPD, immunosuppression, heart failure), severity scores, and individual risk factors. The example above addresses community-acquired bacterial pneumonia with COPD, but your patient may have different clinical priorities.

CarePlanHQ generates individualized pneumonia care plans from your patient assessment. Enter the clinical data — respiratory findings, vital signs, lab values, comorbidities — and receive a complete NANDA-I care plan with mapped interventions, measurable outcomes, and a formatted PDF in seconds.